FindTrial
Sign In

Comparison of postoperative analgesic effects of thoracic paravertebral block, erector spinae plane block and posterior vertebral block in patients undergoing thoracoscopic surgery: a randomized, controlled, non-inferiority trial

Comparison of postoperative analgesic effects of thoracic paravertebral block, erector spinae plane block and posterior vertebral block in patients undergoing thoracoscopic surgery: a randomized, controlled, non-inferiority trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069985
Enrollment
Unknown
Registered
2023-03-30
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumor

Interventions

Group P (paravertebral block group):paravertebral block
Group E (erector spinae block group):Erector spinae plane block
Group R (retrolaminar block group):retrolaminar block

Sponsors

The First Affiliated Hospital of Kunming Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Selective single-port thoracoscopic surgery; (2) Age 18-65 years old; (3) ASA classification I-III; (4) Patients and their families agreed and signed the anesthesia consent before operation, and stayed in hospital for observation for more than 3 days after operation; (5) There is no serious language communication obstacle, and the postoperative follow-up content can be agreed and accepted after explanation; (6) No cognitive impairment.

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, lung, brain, liver and kidney dysfunction and severe endocrine system diseases; (2) Patients with coagulation dysfunction or long-term anticoagulation before operation; (3) Patients with low back pain or other low back problems (such as scoliosis and puncture site infection); (4) BMI>30kg/m2 (5) patients transferred to open chest surgery; (6) Patients with long-term antidepressant or psychotropic drug use or alcoholism; (7) Patients with mental illness or communication disorder or refusing to cooperate; (8) those who are allergic to the drugs used in the study or who have contraindications to anesthesia; (9) Ultrasonic coupling agent allergy.

Design outcomes

Primary

MeasureTime frame
The area under ROC curve of NRS with time at rest and deep inhalation after operation.;Incidence of complications of adverse events at 48 hours after operation.;—

Secondary

MeasureTime frame
QoR-15 scale score 24 hours after operation.;Length of stay (LOS);Opioid consumption 24 hours after operation.;Time of first use of analgesic drugs after operation.;—

Countries

China

Contacts

Public ContactYu Fang

The First Affiliated Hospital of Kunming Medical University

fangyu@ydyy.cn+86 13888091314

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026